Medicine
Vermox 500 mg chewable tablet
Vermox 500 mg chewable tablet is a prescription medicine containing Mebendazole for oral use, marketed by Janssen Pharmaceuticals, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store below 30°C.
Key facts
- Active ingredient (INN)
- Mebendazole
- Brand
- Vermox
- Strength
- 500 mg
- Dosage form
- Chewable tablet
- Route
- Oral
- Packs
- 200 tablets
- Marketing authorisation holder
- Janssen Pharmaceuticals
- Manufacturer
- Janssen Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store below 30°C.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- P02CA01 Mebendazole
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 20 October 2016
- Identifiers
- RxCUI 1855385, 1855387DailyMed set ID a720c424-517a-461b-8e13-6c37caf8aa3fNDC 50458-675Application NDA208398
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 200 tablet, chewable in 1 bottle | 50458-675-20 | Janssen Pharmaceuticals | 20 October 2016 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 28 June 1974 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Mebendazole is an anthelmintic indicated for the treatment of patients one year of age and older with gastrointestinal infections caused by Ascaris lumbricoides (roundworm) and Trichuris trichiura (whipworm). It is available as chewable tablets for oral use. MedsAcross supplies Mebendazole for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about MebendazoleFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- VERMOX prescribing information (Janssen Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Vermox 500 mg chewable tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.